Despite this role for PMCA4 in cardiac hypertrophy, there is no evidence that human ATP2B4 is associated with CVD; genome-wide association studies (GWAS) have to date been unable to associate SNPs within ATP2B4 with any CVD (Tabara et al., 2010). Here, ATP2B4 is linked to cardiac hypertrophy.